Repository logo
  • English
  • Srpski (lat)
  • Српски
Log In
  1. Home
  2. Browse by Author

Browsing by Author "Parojčić, Aleksandra (55266544000)"

Filter results by typing the first few letters
Now showing 1 - 4 of 4
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Psychometric evaluation of the Serbian version of the Stigma Scale of Epilepsy (SSE)
    (2023)
    Lalatović, Staša (57843883800)
    ;
    Smiljanić, Isidora (58686177900)
    ;
    Ristić, Aleksandar J. (7003835405)
    ;
    Cvorović, Durđica (58685817600)
    ;
    Golubović, Violeta (58685997700)
    ;
    Parojčić, Aleksandra (55266544000)
    ;
    Baščarević, Vladimir (36485908900)
    ;
    Krstić, Nadežda (55546724000)
    ;
    Milovanović, Maja (57198020720)
    Objective: To evaluate the psychometric properties of the Serbian-language version of the Stigma Scale of Epilepsy (SSE). Methods: The sample consisted of 108 patients with epilepsy (PWE) (60.2 % were female, age range: 19–67 years) and 102 students (86.3 % were female, age range: 18–47 years). The study encompassed two phases: (1) translation of the SSE into Serbian using the back-translation technique, and (2) evaluation of reliability and construct validity of the Serbian-language version of SSE. In addition to the SSE, the PWE filled out a Neurological Disorders Depression Inventory for Epilepsy (NDDI-E), Patient Health Questionnaire-9 (PHQ-9), and Generalized Anxiety Disorder-7 (GAD-7). The socio-demographic and clinical variables were noted for each patient by the semistructured interview. Besides completing the SSE, the students were asked if they knew anyone with epilepsy. The reliability of the questionnaire was tested by assessing the internal consistency of the scale (Cronbach's α), while construct validity was assessed by factor analysis, method of known-groups validation, and correlation analysis. Results: SSE demonstrates a satisfactory level of reliability in both samples, with Cronbach's α of 0.86 in the PWE sample and 0.90 in the student sample. Using exploratory factor analysis, four factors were identified in both samples, corresponding relatively well with the scale domains originally produced, with a few exceptions described. Adverse effects (AEs) of antiseizure medications (ASMs) and driving ability significantly influenced SSE scores, but there were no significant effects of other socio-demographic and clinical variables on epilepsy-related stigma in the PWE sample. In addition, depression severity significantly influenced SSE scores (based on NDDI-E cut-off score), with the SSE showing a positive association with PHQ-9 (r = 0.42, p < .001) and GAD-7 (r = 0.35, p < .001) as well. Regarding the student sample, the effects of personal knowledge of someone with epilepsy on SSE scores were found to be significant. Besides, students (M = 46.28, SD = 16.43) reported higher epilepsy-related stigma than patients (M = 40.66, SD = 17.01), t(208) = 2.43, p < .05, d = 0.34. Conclusion: The Serbian version of the SSE has good psychometric properties and represents a useful tool for assessing epilepsy-related stigma in both patients and the general population. © 2023 Elsevier Inc.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Psychometric evaluation of the Serbian version of the Stigma Scale of Epilepsy (SSE)
    (2023)
    Lalatović, Staša (57843883800)
    ;
    Smiljanić, Isidora (58686177900)
    ;
    Ristić, Aleksandar J. (7003835405)
    ;
    Cvorović, Durđica (58685817600)
    ;
    Golubović, Violeta (58685997700)
    ;
    Parojčić, Aleksandra (55266544000)
    ;
    Baščarević, Vladimir (36485908900)
    ;
    Krstić, Nadežda (55546724000)
    ;
    Milovanović, Maja (57198020720)
    Objective: To evaluate the psychometric properties of the Serbian-language version of the Stigma Scale of Epilepsy (SSE). Methods: The sample consisted of 108 patients with epilepsy (PWE) (60.2 % were female, age range: 19–67 years) and 102 students (86.3 % were female, age range: 18–47 years). The study encompassed two phases: (1) translation of the SSE into Serbian using the back-translation technique, and (2) evaluation of reliability and construct validity of the Serbian-language version of SSE. In addition to the SSE, the PWE filled out a Neurological Disorders Depression Inventory for Epilepsy (NDDI-E), Patient Health Questionnaire-9 (PHQ-9), and Generalized Anxiety Disorder-7 (GAD-7). The socio-demographic and clinical variables were noted for each patient by the semistructured interview. Besides completing the SSE, the students were asked if they knew anyone with epilepsy. The reliability of the questionnaire was tested by assessing the internal consistency of the scale (Cronbach's α), while construct validity was assessed by factor analysis, method of known-groups validation, and correlation analysis. Results: SSE demonstrates a satisfactory level of reliability in both samples, with Cronbach's α of 0.86 in the PWE sample and 0.90 in the student sample. Using exploratory factor analysis, four factors were identified in both samples, corresponding relatively well with the scale domains originally produced, with a few exceptions described. Adverse effects (AEs) of antiseizure medications (ASMs) and driving ability significantly influenced SSE scores, but there were no significant effects of other socio-demographic and clinical variables on epilepsy-related stigma in the PWE sample. In addition, depression severity significantly influenced SSE scores (based on NDDI-E cut-off score), with the SSE showing a positive association with PHQ-9 (r = 0.42, p < .001) and GAD-7 (r = 0.35, p < .001) as well. Regarding the student sample, the effects of personal knowledge of someone with epilepsy on SSE scores were found to be significant. Besides, students (M = 46.28, SD = 16.43) reported higher epilepsy-related stigma than patients (M = 40.66, SD = 17.01), t(208) = 2.43, p < .05, d = 0.34. Conclusion: The Serbian version of the SSE has good psychometric properties and represents a useful tool for assessing epilepsy-related stigma in both patients and the general population. © 2023 Elsevier Inc.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Surgical management of meningoencephalocele in temporal bone associated with pharmacoresistant epilepsy: report of two cases
    (2019)
    Pejović, Aleksa T. (57188722535)
    ;
    Ristić, Aleksandar J. (7003835405)
    ;
    Baščarević, Vladimir (36485908900)
    ;
    Brajković, Leposava (55176778800)
    ;
    Berisavac, Ivana (6507392420)
    ;
    Vojvodić, Nikola (6701469523)
    ;
    Parojčić, Aleksandra (55266544000)
    ;
    Sokić, Dragoslav (35611592800)
    We report good outcome after surgical treatment of two patients with meningoencephalocele associated with pharmacoresistant temporal lobe epilepsy. Surgical management of meningoencephaloceles may result in seizure freedom, although optimal surgical strategy is still controversial. © 2017, © 2017 The Neurosurgical Foundation.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    VALIDATION OF THE BRIEF INTERNATIONAL COGNITIVE ASSESSMENT FOR MULTIPLE SCLEROSIS (BICAMS) IN A LARGE COHORT OF RELAPSING-REMITTING MS PATIENTS; [VALIDACIJA KRATKE MEĐUNARODNE KOGNITIVNE PROCJENE MULTIPLE SKLEROZE U VELIKOJ KOHORTI BOLESNIKA S RELAPSNO-REMITENTNOM MULTIPLOM SKLEROZOM]
    (2022)
    Drulović, Jelena (55886929900)
    ;
    Tončev, Gordana (6506651230)
    ;
    Nadj, Čongor (6507608134)
    ;
    Obradović, Dragana (7005065235)
    ;
    Eraković, Jevto (57192306386)
    ;
    Mesaroš, Šarlota (7004307592)
    ;
    Čukić, Mirjana (55891936800)
    ;
    Aleksić, Dejan (56893486100)
    ;
    Andabaka, Marko (57207949404)
    ;
    Ivanović, Jovana (57196371316)
    ;
    Jovanović, Aleksa (57216047949)
    ;
    Kostić, Marina (57812840500)
    ;
    Marić, Gorica (56433592800)
    ;
    Marković, Aleksandar (57813232900)
    ;
    Martinović, Vanja (56925159700)
    ;
    Parojčić, Aleksandra (55266544000)
    ;
    Perić, Stojan (35750481700)
    ;
    Sakalaš, Lorand (56156559400)
    ;
    Suknjaja, Vesna (35727065400)
    ;
    Vesić, Katarina (55873795900)
    ;
    Vojvodić, Sofija (57812055000)
    ;
    Vuković, Tijana (57812840600)
    ;
    Benedict, Ralph H. B. (7102333960)
    ;
    Pekmezović, Tatjana (7003989932)
    Cognitive impairment is one of the most frequently reported symptoms in persons with multiple sclerosis (MS). The Brief International Cognitive Assessment for Multiple Sclerosis (BI-CAMS) has been recommended as a standardized international screening and monitoring tool for brief cognitive assessment.The aim of our study was to assess the reliability and validity of the Serbian version of the BICAMS. A total of 500 relapsing-remitting MS (RRMS) patients and 69 age-, gender-and educa-tion-matched healthy control (HC) subjects were examined. All participants performed the BICAMS test battery, which includes the oral version of the Symbol Digit Modalities Test (SDMT), California Verbal Learning Test second edition (CVLT-II), and Brief Visuospatial Memory Test Revised (BVMTR). A ran-domly selected subset of patients were retested one to three weeks after baseline. Statistically significant dif-ferences between patients and HCs were evident on the SDMT and BVMTR (p<0.001). HCs had higher CVLT-II scores but this difference did not reach statistical significance (p=0.063). Cognitive impairment, defined as an abnormal test score on ≥1 subtest, was found in 62.9% of MS patients.There were statistically significant correlations between BICAMS scores and age, education, EDSS and disease duration in patient sample. Test-retest reliability was confirmed with Pearson correlation coefficient of 0.70 in all measures. This study supported the reliability and validity of the Serbian BICAMS, although the CVLT-II version tested here lacked sensitivity to detect MS compared to healthy volunteers. © 2022, Dr. Mladen Stojanovic University Hospital. All rights reserved.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Privacy policy
  • End User Agreement
  • Send Feedback